Submitted by Anonymous (not verified) on 17 October 2025 - 13:35
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised